Biotech Finances: Keep abreast with the latest news from the biotech industry

NewsGuard 100/100 Score

The biotech industry moves fast – very fast! Make sure you don’t get left behind. Read “Biotech Finances” to ensure you keep ahead of the field with the latest news from the biotech industry. Biotech Finances is the leading publication for the biotech industry from Europe. The French-language version has more than 6,000 subscribers and industry leaders rely on it to keep them up-to-date with the latest news and market intelligence. In response to regular requests from the industry, an English language version was launched in January 2009 and has met with great success. To give new readers the chance to prove the value of Biotech Finances for themselves, the publishers are pleased to offer a three-week free trial.

Try the weekly newsletter and comprehensive website for free

Subscribers receive a weekly newsletter. You’ll find it packed with news on the latest mergers, acquisitions and start-ups; financing methods; legal and intellectual property issues; national and regional government structures and support. In addition, every week there are interviews with experts in key areas such as finance, law and intellectual property.

Furthermore, subscribers gain password protected access to the Biotech Finances’ website, which includes a wealth of information such as breaking news and archives of Biotech Finances’ articles.

These online resources are available in French and, from January 2009, in English.

Why is Biotech Finances different?

Publisher Jacques-Bernard Taste explains, “Biotech Finances does not recycle news stories from other publications. It has a team of specialists who actually talk to key players in the field, such as CEOs of leading companies, politicians and regulators”. As a result, subscribers find news in Biotech Finances that can’t be found elsewhere. In addition, its tables of financial transactions in the biotechnology field provide early notification of key M&A activity in the sector. Each year, more than 400,000 stakeholders from the life sciences sector around the world read the newsletter and access its online information and databases. Ultimately, Biotech Finances provides the information businesses need to succeed in the dynamic field of biotechnology.

Source:

Biotech Finances

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nuclera eProtein Discovery system installed at leading academic institutes